A determinant for central nervous system persistence localized in the capsid of Theiler's murine encephalomyelitis virus by using recombinant viruses

Journal of Virology

Volumn 72, Issue 2, 1998, Pages 1662-1665

  Adami, Cecilia ^a,b,e   Pritchard, Arthur E ^c   Knauf, Todd ^a,b   Luo, Ming ^d   Lipton, Howard L ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b EVANSTON HOSPITAL   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

SIGNAL PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEMYELINATING DISEASE; DEMYELINATION; MOUSE; MURINE ENCEPHALOMYELITIS VIRUS; NONHUMAN; PRIORITY JOURNAL; VIRUS CAPSID; VIRUS RECOMBINANT;

EID: 0031951170     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.2.1662-1665.1998     Document Type: Article

References (20)

1. Brahic, M. Personal communication.
2. Caggana, M., P. Chan, and A. Ramsingh. 1993. Identification of a single amino acid residue in the capsid protein VP1 of coxsackievirus B4 that determines the virulent phenotype. J. Virol. 67:4797-4803.
3. Calenoff, M. A., K. S. Faaberg, and H. L. Lipton. 1990. Genomic regions of neurovirulence and attenuation in Theiler's murine encephalomyelitis. Proc. Natl. Acad. Sci. USA 87:978-982.
4. Filman, D. J., R. Syed, M. Chow, A. J. Macadam, P. D. Minor, and J. M. Hogle. 1989. Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus. EMBO J. 8:1567-1579.
5. Fu, J., M. Rodriguez, and R. P. Roos. 1990. Strains from both Theiler's virus subgroups encode a determinant for demyelination. J. Virol. 64:6345-6348.
6. Grant, R. A., D. J. Filman, R. S. Fujinami, J. P. Icenogle, and J. M. Hogle. 1992. Three-dimensional structure of Theiler's virus. Proc. Natl. Acad. Sci. USA 89:2061-2065.
7. Horton, R. M., S. N. Ho, J. K. Pullen, H. D. Hunt, Z. Cai, and L. R. Pease. 1993. Gene splicing by overlap extension. Methods Enzymol. 217:270-279.
8. Jarousse, N., R. A. Grant, J. M. Hogle, L. Zhang, A. Senkowski, R. P. Roos, T. Michiels, M. Brahic, and A. McAllister. 1994. A single amino acid change determines persistence of a chimeric Theiler's virus. J. Virol. 68:3364-3368.
9. Lipton, H. L. 1980. Persistent Theiler's murine encephalomyelitis virus infection in mice depends on plaque size. J. Gen. Virol. 46:169-177.
10. Luo, M., H. Cunheng, K. S. Toth, C. X. Zhang, and H. L. Lipton. 1992. Three-dimensional structure of Theiler's murine encephalomyelitis virus (BeAn strain). Proc. Natl. Acad. Sci. USA 89:2409-2413.
11. Luo, M., K. S. Toth, L. Zhou, A. Pritchard, and H. L. Lipton. 1995. The structure of a highly virulent Theiler's murine encephalomyelitis virus (GDVII) and implications for determinants of viral persistence. Virology 220: 246-250.
12. McAllister, A., F. Tangy, C. Aubert, and M. Brahic. 1989. Molecular cloning of the complete genome of Theiler's virus, strain DA, and production of infectious transcripts. Microb. Pathog. 7:381-388.
13. McAllister, A., F. Tangy, C. Aubert, and M. Brahic. 1990. Genetic mapping of the ability of Theiler's virus to persist and demyelinate. J. Virol. 64:4252-4257. (Erratum, 67:2427, 1993.)
14. Ohara, Y., S. Stein, J. Fu, L. Stillman, L. Klaman, and R. P. Roos. 1988. Molecular cloning and sequence determination of DA strain of Theiler's murine encephalomyelitis virus. Virology 164:245-255.
15. Pevear, D. C., J. Borkowski, M. Calenoff, C. K. Oh, B. Ostrowski, and H. L. Lipton. 1988. Insights into Theiler's virus neurovirulence based on a genomic comparison of the neurovirulent GDVII and less virulent BeAn strains. Virology 165:1-12.
16. Pevear, D. C., C. K. Oh, L. L. Cunningham, M. Calenoff, and M. Jubelt. 1990. Localization of genomic regions specific for the attenuated mouse-adapted poliovirus type 2 strain W-2. J. Gen. Virol. 71:43-52.
17. Pritchard, A. E., K. Jensen, and H. L. Lipton. 1993. Assembly of Theiler's virus recombinants used in mapping determinants of neurovirulence. J. Virol. 67:3901-3907.
18. Ren, R. B., E. G. Moss, and V. R. Racaniello. 1991. Identification of two determinants that attenuate vaccine-related type 2 poliovirus. J. Virol. 65: 1377-1382.
19. Rodriguez, M., and R. P. Roos. 1992. Pathogenesis of early and late disease in mice infected with Theiler's virus, using intratypic recombinant GDVII/DA viruses. J. Virol. 66:217-225.
20. Zhang, L., A. Senkowski, B. Shim, and R. P. Roos. 1993. Chimera cDNA studies of Theiler's murine encephalomyelitis virus neurovirulence. J. Virol. 65:4404-4408.